Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.
Zhu CS, Huang WY, Pinsky PF, Berg CD, Sherman M, Yu KJ, Carrick DM, Black A, Hoover R, Lenz P, Williams C, Hawkins L, Chaloux M, Yurgalevitch S, Mathew S, Miller A, Olivo V, Khan A, Pretzel SM, Multerer D, Beckmann P, Broski KG, Freedman ND. Zhu CS, et al. Among authors: mathew s. Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1635-1642. doi: 10.1158/1055-9965.EPI-16-0506. Epub 2016 Sep 15. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27635065 Free PMC article. Clinical Trial.
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.
Black A, Huang WY, Wright P, Riley T, Mabie J, Mathew S, Ragard L, Hermansen S, Yu K, Pinsky P, Prorok PC, Freedman ND, Hoover RN. Black A, et al. Among authors: mathew s. Rev Recent Clin Trials. 2015;10(3):238-45. doi: 10.2174/157488711003150928130654. Rev Recent Clin Trials. 2015. PMID: 26435289 Free PMC article. Review.
The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
Kleinman SH, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, Carrick D, Mathew S, Wright DJ, Cable R, Ness P, Gajic O, Hubmayr RD, Looney MR, Kakaiya RM; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II. Kleinman SH, et al. Among authors: mathew s. Transfusion. 2011 Oct;51(10):2078-91. doi: 10.1111/j.1537-2995.2011.03120.x. Epub 2011 Mar 29. Transfusion. 2011. PMID: 21446938 Free PMC article.
The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort.
Fishbein HA, Birch RJ, Mathew SM, Sawyer HL, Pulver G, Poling J, Kaelber D, Mardon R, Johnson MC, Pace W, Umbel KD, Zhang X, Siegel KR, Imperatore G, Shrestha S, Proia K, Cheng Y, McKeever Bullard K, Gregg EW, Rolka D, Pavkov ME. Fishbein HA, et al. Among authors: mathew sm. Healthc (Amst). 2020 Dec;8(4):100458. doi: 10.1016/j.hjdsi.2020.100458. Epub 2020 Oct 1. Healthc (Amst). 2020. PMID: 33011645 Free PMC article.
How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? Demonstrated with the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric V2V database protocol.
Birch RJ, Umbel K, Karafin MS, Goel R, Mathew S, Pace W; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Birch RJ, et al. Among authors: mathew s. Transfusion. 2023 Sep;63(9):1623-1632. doi: 10.1111/trf.17507. Epub 2023 Aug 19. Transfusion. 2023. PMID: 37596918
Factors influencing the decision to donate: racial and ethnic comparisons.
Glynn SA, Schreiber GB, Murphy EL, Kessler D, Higgins M, Wright DJ, Mathew S, Tu Y, King M, Smith JW; Retrovirus Epidemiology Donor Study. Glynn SA, et al. Among authors: mathew s. Transfusion. 2006 Jun;46(6):980-90. doi: 10.1111/j.1537-2995.2006.00831.x. Transfusion. 2006. PMID: 16734815
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
Stone M, Di Germanio C, Wright DJ, Sulaeman H, Dave H, Fink RV, Notari EP, Green V, Strauss D, Kessler D, Destree M, Saa P, Williamson PC, Simmons G, Stramer SL, Opsomer J, Jones JM, Kleinman S, Busch MP; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Stone M, et al. Clin Infect Dis. 2022 Mar 9;74(5):871-881. doi: 10.1093/cid/ciab537. Clin Infect Dis. 2022. PMID: 34111244 Free PMC article.
The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.
Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, Busch MP, Chapman K, Dinardo C, Hendrickson J, Hod EA, Kelly S, Luban N, Mast A, Norris P, Custer B, Sabino E, Sachais B, Spencer BR, Stone M, Kleinman S; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Josephson CD, et al. Among authors: mathew s. Transfusion. 2022 May;62(5):982-999. doi: 10.1111/trf.16869. Epub 2022 Apr 19. Transfusion. 2022. PMID: 35441384 Free PMC article.
1,659 results